Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

K. Scott Baker, MD, MS, Anna Hassebroek, MPH, Karen Ballen, MD, Carolyn Bigelow, MD, Haydar Frangoul, MD, Cheryl Hardy, PhD, Stephanie Lee, MD,MPH, Galen Switzer, PhD, J. Douglas Rizzo, MD, John P. Klein, PhD, Navneet Majhail, MD,MS, Stella Davies, MB.BS,PhD

Blood (2007) 110 (11): 3064.

https://doi.org/10.1182/blood.V110.11.3064.3064

Published: 2007

Journal Articles

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Meghan Delaney, DO, Beow Yeap, Sc.D, Richard L. Haspel, MD, PhD, Thomas R. Spitzer, MD, Steven L. McAfee, MD, Bimalangshu Dey, MD, PhD, Eyal Attar, MD, Grace Kao, MD, Edwin Alyea, MD, Stephanie Lee, MD, Corey Cutler, MD, Vincent Ho, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Ballen Karen, MD

Blood (2007) 110 (11): 2032.

https://doi.org/10.1182/blood.V110.11.2032.2032

Published: 2007

Journal Articles

Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.

Daniel J. Weisdorf, MD, Stephen Spellman, John Klein, PhD, Michael D. Haagenson, MS, Mary Horowitz, MD, Stephanie Lee, MD, MPH, Claudio Anasetti, MD, Michelle Setterholm, Rebecca Drexler, BS, AAS, Martin Maiers, Roberta King, Dennis Confer, MD

Blood (2007) 110 (11): 45.

https://doi.org/10.1182/blood.V110.11.45.45

Published: 2007

Journal Articles

Impact of Prior Therapy with Imatinib Mesylate on the Outcome of Hematopoietic Cell Transplantation (HCT) for Chronic Myeloiod Leukemia (CML).

Stephanie Lee, MD, Richard Maziarz, MD, Manisha Kukreja, MBBS, MPH, Tao Wang, PhD, Sergio Giralt, MD, Jeffrey Szer, MBBS, Ann Woolfrey, MD, Mukta Arora, MD, MS

Blood (2007) 110 (11): 738.

https://doi.org/10.1182/blood.V110.11.738.738

Published: 2007

Journal Articles

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Karen K. Ballen, MD, Thomas R. Spitzer, MD, Beow Yeap, ScD, McAfee Steve, MD, Bimalanghsu R. Dey, MD, Eyal Attar, MD, Edwin Alyea, MD, Corey Cutler, MD, Vincent Ho, MD, Stephanie Lee, MD, Robert Soiffer, MD, Joseph H. Antin, MD

Blood (2005) 106 (11): 2048.

https://doi.org/10.1182/blood.V106.11.2048.2048

Published: 2005

NARROW

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.

Impact of Prior Therapy with Imatinib Mesylate on the Outcome of Hematopoietic Cell Transplantation (HCT) for Chronic Myeloiod Leukemia (CML).

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Email alerts

ASH Publications

American Society of Hematology

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.

Impact of Prior Therapy with Imatinib Mesylate on the Outcome of Hematopoietic Cell Transplantation (HCT) for Chronic Myeloiod Leukemia (CML).

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only